Real-World Treatment Patterns & Characteristics of Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Retrospective Analysis of US Claims (2017-2024)

被引:0
|
作者
Burke, John M. [1 ,2 ]
Zhou, Ziqi [3 ]
Gutierrez, Cynthia [3 ]
Shao, Anran [4 ]
Boyd, Marley [4 ]
Noshad, Sina [3 ]
Hohlbauch, Andriana [3 ]
Liu, Nicholas [5 ]
Repetny, Karen [5 ]
Fanale, Michelle [5 ]
Mitchell, Betsy [5 ]
Phillips, Tycel [6 ]
机构
[1] Sarah Cannon Res Inst, Aurora, CO USA
[2] Rocky Mt Canc Ctr, Aurora, CO USA
[3] Genesis, Hoboken, NJ USA
[4] Genesis Res Grp, Hoboken, NJ USA
[5] Pfizer, New York, NY USA
[6] City Of Hope, Dept Hematol & Oncol, Duarte, CA USA
关键词
D O I
10.1182/blood-2024-203554
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:7810 / 7811
页数:2
相关论文
共 50 条
  • [21] Real-world costing analysis for diffuse large B-cell lymphoma in British Columbia
    Costa, S.
    Scott, D. W.
    Steidl, C.
    Peacock, S. J.
    Regier, D. A.
    CURRENT ONCOLOGY, 2019, 26 (02) : 108 - 113
  • [22] BURDEN OF DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN GERMANY - A RETROSPECTIVE STATUTORY HEALTH INSURANCE CLAIMS DATA ANALYSIS
    Moertl, B.
    Beier, D.
    Schmidt, C.
    von Bergwelt, M.
    Dreyling, M.
    Berger, K.
    VALUE IN HEALTH, 2022, 25 (12) : S222 - S222
  • [23] A Retrospective Claims Analysis of Real-World Treatment Patterns and Economic Burden Among Patients with Marginal Zone Lymphoma in the US
    Garg, Mahek
    Satija, Ambika
    Song, Yan
    Meade, Ben
    Signorovitch, James
    Gandra, Shravanthi
    BLOOD, 2024, 144 : 5104 - 5105
  • [24] Real-World Characteristics, Treatment Patterns, Health Care Resource Use, and Costs of Patients with Diffuse Large B-Cell Lymphoma in the U.S
    Yang, Xiaoqin
    Laliberte, Francois
    Germain, Guillaume
    Raut, Monika
    Duh, Mei Sheng
    Sen, Shuvayu S.
    Lejeune, Dominique
    Desai, Kaushal
    Armand, Philippe
    ONCOLOGIST, 2021, 26 (05): : E817 - E826
  • [25] Utilization of real-world data in assessing treatment effectiveness for diffuse large B-cell lymphoma
    Nowakowski, Grzegorz
    Maurer, Matthew J.
    Cerhan, James R.
    Dey, Debarshi
    Sehn, Laurie H.
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (01) : 180 - 192
  • [26] TREATMENT PATTERNS AMONG PATIENTS WITH RELAPSED/REFRACTORY (RIR) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) WHO ARE INELIGIBLE FOR TRANSPLANTATION - A REAL-WORLD STUDY USING FRENCH PMSI
    Di Blasi, R.
    Thieblemont, C.
    Haioun, C.
    Mayaud, A. C.
    Sala, Sackmann L.
    Diez-Andreu, P.
    Bugnard, F.
    Goguillot, M.
    Chillotti, L.
    Finzi, J.
    Benard, S.
    VALUE IN HEALTH, 2022, 25 (12) : S218 - S218
  • [27] IDENTIFYING TREATMENT PATTERNS FOR DIFFUSE LARGE B-CELL LYMPHOMA IN REAL-WORLD DATA USING UNSUPERVISED MACHINE LEARNING
    Wang, Y.
    Vanness, D.
    VALUE IN HEALTH, 2023, 26 (06) : S287 - S287
  • [28] Treatment of diffuse large B-cell lymphoma (DLBCL) in routine care 2008-2017
    Weide, R.
    Feiten, S.
    Chakupurakal, G.
    Friesenhahn, V.
    Kleboth, K.
    Koeppler, H.
    Lutschkin, J.
    Thomalla, J.
    van Roye, C.
    Heymanns, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 47 - 47
  • [29] Characteristics and Outcome of critically ill Patients with diffuse large B-Cell Lymphoma (DLBCL)
    Wohlfarth, P.
    Carlstroem, A.
    Staudinger, T.
    Clauss, S.
    Skrabs, K.
    Porpaczy, E.
    Schiefer, A. I.
    Valent, P.
    Jaeger, U.
    Sperr, W. R.
    Schellongowski, P.
    MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2015, 110 (04) : 297 - 297
  • [30] Real-world outcomes of diffuse large B-cell lymphoma in the biosimilar era
    Nair, Reena
    Bhat, Gull Mohammad
    Agrawal, Narendra
    Sengar, Manju
    Malhotra, Pankaj
    Nityanand, Soniya
    Lele, Chitra
    Reddy, Pramod
    Kankanwadi, Suresh
    Maharaj, Narendra
    FRONTIERS IN ONCOLOGY, 2023, 13